
RNST
USDRenasant Corporation Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$33.310
Kõrge
$34.040
Madal
$33.050
Maht
0.30M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
3.2B
Tööstusharu
Banks - Regional
Riik
United States
Kauplemisstatistika
Keskmine maht
0.54M
Börs
NYQ
Valuuta
USD
52 nädala vahemik
Tehisintellekti analüüsiaruanne
Viimati uuendatud: 4. nov 2025RNST - Renasant Corporation: A 3-Minute Read on Whether to Buy, Hold, or Walk Away
Key Takeaway: Renasant (RNST) is trading at $33.59, just 1.5% above the analyst consensus target of $33.10. The stock has been on a tear, up 25% in the past month, but the fundamentals are lagging. Here's what matters:
- Valuation: Trading at 13.3x forward earnings, slightly rich vs. peers.
- Momentum: Technical indicators are flashing bullish, but the stock is nearing a key resistance level at $34.00.
- Catalyst: Recent dividend hike and strong Q3 earnings have investors excited, but the stock is already pricing in much of the good news.
Bottom line: If you're a short-term trader, the risk-reward is skewed to the downside. Long-term investors may want to wait for a pullback to the $30-$31 range, where the risk-reward becomes more attractive.
1. Price Action & Momentum
- Current Price: $33.59 (as of Nov 4, 2025)
- 52-week range: $26.97 - $40.40
- Key resistance: $34.00 (a break above this level could open the door to $40+)
- Key support: $32.50 (a break below this level could trigger a sell-off to $30.00)
2. Analyst Sentiment
- 7 Buy ratings vs. 0 Sell ratings (TipRanks consensus)
- Average price target: $42.43 (26% upside potential)
- Recent upgrades: TD Cowen (Buy, PT $44) and Hovde Group (Outperform, PT $41)
3. Financial Health Check
- Revenue: $2.3B (up 18% YoY)
- Net income: $1.2B (up 25% YoY)
- Dividend: $0.23/share quarterly (up 15% YoY)
- P/E ratio: 13.3x (vs. 11.3x sector median)
- P/B ratio: 1.1x (vs. 1.0x sector median)
4. Key Risk Factors
- Valuation risk: Trading at a 17% premium to book value, leaving little room for error.
- Interest rate sensitivity: As a regional bank, RNST is highly sensitive to interest rate changes.
- Credit risk: The company has $1.2B in loans that could be at risk if the economy turns south.
5. The Trade Setup
- Entry point: $33.59 (current price)
- Stop-loss: $32.49 (3% below current price)
- Take-profit: $41.75 (conservative target based on analyst consensus)
- Risk-reward: 1:1.3 (unattractive for short-term traders)
Conclusion: Renasant is a quality bank, but the stock appears to be ahead of itself in the short term. If you're a long-term investor, you may want to wait for a better entry point. If you're a trader, the risk-reward is poor at current levels.
Disclosure: This is not financial advice. Consult a financial advisor before making any investment decisions.
Seotud uudised
TD Cowen Maintains Buy on Renasant, Lowers Price Target to $44
TD Cowen analyst Janet Lee maintains Renasant with a Buy and lowers the price target from $45 to $44.
Hovde Group Upgrades Renasant to Outperform, Raises Price Target to $41
Hovde Group analyst David Bishop upgrades Renasant from Market Perform to Outperform and raises the price target from $40 to $41.
Renasant Corporation Increases Quarterly Dividend
TUPELO, Miss., Oct. 28, 2025 (GLOBE NEWSWIRE) -- The board of directors of Renasant Corporation (NYSE:RNST) approved the payment of a quarterly cash dividend of twenty-three cents ($0.23) per share to be paid January
Renasant Corporation Announces Earnings for the Third Quarter of 2025
TUPELO, Miss., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Renasant Corporation (NYSE:RNST) (the "Company") today announced earnings results for the third quarter of 2025. (Dollars in thousands, except earnings per share)Three
Tehisintellekti ennustusBeta
Tehisintellekti soovitus
Uuendatud kell: 5. nov 2025, 08:24
64.4% Kindlus
Risk ja kauplemine
Sisenemispunkt
$33.66
Võta kasum
$34.53
Peata kahjum
$32.78
Põhitegurid
Seotud aktsiad
GREE
Greenidge Generation Holdings Inc.
SCM
Stellus Capital Investment Corporation
HPS
John Hancock Preferred Income Fund III Preferred Income Fund III
INSW
International Seaways Inc.
SNTI
Senti Biosciences Inc.
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.